chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dry heaving; dehydration; night sweats; rash from the injection site, down to her elbow; fever of 103.8; chills; vomiting; diarrhea; couldn't eat or drink anything; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (couldn't eat or drink anything), RETCHING (dry heaving), DEHYDRATION (dehydration) and NIGHT SWEATS (night sweats) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS and CITALOPRAM.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DIARRHOEA (diarrhea), DECREASED APPETITE (couldn't eat or drink anything), NIGHT SWEATS (night sweats), INJECTION SITE RASH (rash from the injection site, down to her elbow), PYREXIA (fever of 103.8), CHILLS (chills) and VOMITING (vomiting). On an unknown date, the patient experienced RETCHING (dry heaving) and DEHYDRATION (dehydration). At the time of the report, DIARRHOEA (diarrhea), DECREASED APPETITE (couldn't eat or drink anything), RETCHING (dry heaving), DEHYDRATION (dehydration), NIGHT SWEATS (night sweats), INJECTION SITE RASH (rash from the injection site, down to her elbow), PYREXIA (fever of 103.8), CHILLS (chills) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Body temperature: 103.8° (High) 103.8°.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
The patient was given a Moderna vaccine on 10/22/21. A 30 day expiration date of 11/5/2021 was put on the vial. The lot number was not in our system and our pharmacy was notified to enter the lot number. It was discovered the lot number was not in the system because it had expired on 10/13/2021.
I developed poly arthritis in my fingers and knees.   I have positive ANA, anti-centromere, with extra antibodies.  In the very beginning my family doctor did not believe it was from the vaccine.   After several weeks of being in pain taking steroids, and prednisone she finally sent me to see Doctor an arthritis  / rheumatologist.   As of today I still have pain and soreness in my joints.   I am taking prednisone and hydroxychloroquine. At my appointment yesterday he suggested I reach out to you to see if any one else has come down this these symptoms. He said you are free to contact him.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 23-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication list was not provided. It was reported that the vaccines were stored in a freezer and one to 2 vials were taken and placed in fridge each day as needed. It was reported that no treatment was given to the patients.
nose bleed that started after vaccine.  no prior history of nose bleed bleeds steadily for approximately then 30 min then faintly for hours
This case was reported by a other health professional via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 11-year-old male patient who received MENVEO (batch number MT6084, expiry date April 2018). Concurrent medical conditions included multiple allergies (allergy to cats, tree nuts and peanuts). On 30th May 2017 16:30, the patient received the 1st dose of MENVEO (intramuscular) .5 ml. In May 2017, less than a week after receiving MENVEO, the patient experienced injection site erythema and feeling hot. On 30th May 2017 18:30, the patient experienced extensive swelling of vaccinated limb. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema and feeling hot were not recovered/not resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema and feeling hot to be related to MENVEO. Additional details were provided as follows: The case was reported by an office manager. The patient received MENVEO in right deltoid. Approximately 2 hours after vaccination, the patient experienced swelling on the right arm. On 31st May 2017, the swelling was increased and redness was also noted. The physician's office was notified. On 1st June 2017, the patient returned to the office with extreme swelling, redness and warmth in an area of the right arm measured as 6 inches in length and 5.5 inches in width. The patient was able to lift the arm.
Swollen lymph node on R side of neck; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported), intramuscularly on the left arm on 04Jan2021 (10:00) at a single dose for COVID-19 immunization at the hospital. Medical history included migraines and penicillin allergy. There were no concomitant medications. The patient previously took chlorhexidine gluconate (HIBICLENS), and had drug allergy. The patient was not pregnant at the time of vaccination. On 23Jan2021 (16:00), the patient had swollen lymph node on the right (R) side of the neck. The patient did not receive any treatment for the reported event. The outcome of the event, swollen lymph node on the right side of the neck, was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination.  Information on the lot/batch number has been requested.
on 1/14/21 patients HR 155 at 0800 per patient's home pulse ox device. arrived at ER, HR 148 at 1130. Continued to stay up even after 2 doses of 10mg iv push Cardizem and one dose of 30mg Cardizem. Cardizem drip started, heparin drip started, patient admitted to hospital
patient was thought to be on her 2nd prime dose in the pfizer series.  It was later discovered (over 1 month later) that patient had received a second booster.  Her series was as follows:  1st dose Moderna 0.5, 2nd dose Moderna 0.5, 1st booster - Pfizer 0.3,  2nd booster (determined later that she was not eligible for this booster) Pfizer 0.3.
Arm soreness began later in the day.  Woke up around midnight with backache, general joint and muscle pain, and nausea.  Has continued to this day.  Have tried ibuprofen and tylenol, with limited results.
On February 20th, she had nasal congestion and a cough. She was diagnosed with her first upper respiratory infection. I took her to the doctor on February 21, 2022, and they advised me to continue with TYLENOL and ibuprofen. I took her back to the doctor the doctor on February 28, 2022, because she could not get rid of the cough. She was prescribed prednisone for 5 days. She was also placed on ZITHROMAX. I do believe her symptoms improved after this visit and she made a complete recovery.
Patient developed flu symptoms (mild) x 3d with fever and some soreness in arm after receiving #1 GARDASIL on June 12, 2008.  Patient reported this on visit when getting #2 GARDASIL 8/14/2008.
difficulty breathing; chest discomfort; Cough; Fever; body aches; body aches , headaches , chest pains; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (chest discomfort), COUGH (Cough), PYREXIA (Fever) and MYALGIA (body aches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (chest discomfort), COUGH (Cough), PYREXIA (Fever), MYALGIA (body aches) and HEADACHE (body aches , headaches , chest pains). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (chest discomfort), COUGH (Cough), PYREXIA (Fever), MYALGIA (body aches) and HEADACHE (body aches , headaches , chest pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
As we were driving home, I started to have a reaction.  My nasal passages swelled, as did the roof of my mouth and throat, and I felt whoozy and my heart racing.  I quickly took a Benadryl caplet, which I had in my purse, and we turned around to go to the urgent care facility in town.  Having had an anaphylatic reaction to sulfur in the past, I was concerned that this was occurring.  At the urgent care facility, the P/A also felt this was a reaction, and administered a steroid shot, told me to continue taking Benadryl every 6 hours, and called in an RX to my pharmacy for steroids
Vomiting + stomach ache believe it from shots she was given yesterday. No delay noted. Pt called back 6am she was no longer vomiting and stomach pain.
Light headed, nauseous, dizzy, shortness of breath. Vomiting cold sweat.
numb/tingle  lip/tongue;  no SOB, no CP, HR 67, O2-98; No stridor, no swelling
received 2 doses less than 4 weeks apart; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 10-month-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 5es77, expiry date 30th June 2023) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT).   On 9th December 2022, the patient received the 2nd dose of Fluarix Quadrivalent 2022-2023 season (intramuscular) and Fluarix Tetra Pre-Filled Syringe Device. On 9th December 2022, unknown after receiving Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 9-Dec-2022 Reporter's comment: The medical assistant that a patient received two doses of Fluarix less than 4 weeks apart in left thigh. The vaccine administration facility was the same as primary reporter. The reporter was someone from safety may follow-up with her, she did not object. The reporter consented to follow-up. Additional supportive information: The patient received 2nd dose of Fluarix earlier than the recommended interval, which led to shortening of vaccine schedule.
warm to touch; red spot occur at injection side and then it turn into big round full red patch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE ERYTHEMA (red spot occur at injection side and then it turn into big round full red patch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE ERYTHEMA (red spot occur at injection side and then it turn into big round full red patch). On 22-Feb-2021, VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE ERYTHEMA (red spot occur at injection side and then it turn into big round full red patch) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Not receiving the 2nd dose after receiving 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not receiving the 2nd dose after receiving 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not receiving the 2nd dose after receiving 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not receiving the 2nd dose after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported. The treatment information was not provided.
Woke up with swelling and redness at injection area, feels warm to the touch and slight stiffness.
several pt recvd Engerix-B; pt reportedly failed to achieve protective titers;
Mother called to complain of sore swollen left arm.  Complains of Weakness, and headache.  Denies Fever.  She was told to seek medical attention if she feels her son needs to be seen. She said he is sleeping now but would update me in the morning or take him to the hospital if need be.
Immediate reaction; tingling from deltoid to ear on left, which last about 2 hrs. Injection site became red, swollen, and was sore to touch and felt like a deep muscle ache which lasted until 1/17/21. Then on 1/18/21, injection site became itchy and very red - worse than at time of injection; very hot and a definite circle of red with is painful, hard to touch and itchy.   Patient was advised by one of the doctors she works with to take an antihistamine, which she did, but it is worse today.   The evening of 1/11/21, patient was very tired and slept 10 hrs, would then take naps after work and through the weekend, then sleeping 10 hours where she usually sleep about 6 hrs per night.  Patient has had this reaction every night since 1/11/21.  On 1/18/21, patient had a sudden onset of dizziness that lasted about a minute;  patient was at work and walking to the front desk to help a patient.  This did not happen until 1/18/21 and has not happened again since.
No adverse event; expired vaccine was administred to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine was administred to patient) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine was administred to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine was administred to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (expired vaccine was administred to patient).    No concomitant medication was reported.  Date the vial was initially stored in the refrigerator on 10-JUL-2023. The vial did not undergo any temperature excursions. Dosage text was reported as unknown. No treatment information was reported.  This case contains information for patient 4 out of 4.   This case was linked to US-MODERNATX, INC.-MOD-2023-733819 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733819:Master case
This spontaneous report was received from a registered nurse refers to an unspecified number of patients who on an unknown date, could have either been administered with a doses of RECOMBIVAX HB (doses, routes and lot numbers not reported) that were exposed to temperature conditions that we could not support. No adverse reactions were reported. Attempts are being made to obtain additional information identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports from the same source. Additional information has been requested.
I have had long Covid symptoms since January they increased after the vaccine. After the vaccine I immediately got a tingly tongue, sinus became inflamed with difficulty breathing, ringing in ears became louder. When I got home had diarrhea right away, muscle aches and crawling feeling across the left shoulder blade which became tender, left side hip (described as shingle type pain). I got a  rash right above belt line 4 days later lasted a day. A week after started experiencing chest pain, palpitations never got a fever. I'm still experiencing the bronchitis issues today.
Itch started around stomach area, first thought it was a bug bite. Eventually hives started spreading all over the chest, back, under the arms, thighs, and now my hands and neck. Was not sure if this was caused by the vaccine until 5/1. Found out that this was a rare non-severe symptom, and  that's when I started taking allergy meds (Benadryl) for Antihistamines and it has relieved the itch temporary. Does not stop the spread of the itchiness.
Date of Admission: 10/10/2022   Date of Discharge: 10/24/2022   Admission Diagnosis: CHF (congestive heart failure), HA class I, acute on chronic, combined (CMS/HCC)  Shortness of breath      Hospital Principal Problem (Discharge Diagnoses): COVID-19
left arm became red and tender 2 days after the shot- and has continued for a total of 3 days without change
I just thought you should know, the redness and swelling had gone away a few days ago and now it is back and hot to the touch.
Wife reported patient became sleepy on way home after vaccination and had MVA without any injury. Reported to clinic 37 days after incident.
Dose administered after 30-day Use By Date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). In 2021, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that 108 patient received vaccine after stored in Refrigerator on 16-SEP-2021  Date(s) of administration of vaccine: 18Oct2021-2Nov2021.  No concomitant information provided by the reporter.  No treatment information provided by the reporter.
ACHINESS; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAR-2021, the subject experienced achiness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achiness on 14-MAR-2021. This report was non-serious. This case, from the same reporter is linked to 20210329147.
pt had a positive COVID test on 1/14/22 at Clinic; 1/22/22 pt brought to hospital by EMS in respiratory extremis, unknown blood pressure or O2 saturation; placed on mechanical ventilation; vasopressors; family decided on DNR for pt and comfort measures; pt died in the hospital
DTAP AND HEP A WAS  ADMINISTERED IN THE LEFT THIGH AND THE NEXT DAY HE HAD A REACTION OF 4 INCHES LONG RED AND SWOLLEN.
Two weeks after injection, heart beats were very irregular and I experienced chest pains and shortness of breath. Never had problems with heart before.  Went to doctor on 10/27/21, did EKG but nothing showed up.   Went to ER on 12/13/21.  Had me wear a heart monitor for two weeks and I follow up with a cardiologist on 1/17/22. Symptoms seem to have gone away now.
Information has been received from a mother concerning her 10 month old daughter who on 12-OCT-2007 was to received RECOMBIVAX HB, (MSD) and was mistakenly given a single dose of VAQTA.  Current patient status was not reported.  A product quality complaint was not reported.  Additional information has been requested.
Daily headaches started April 16 and have not stopped. I also have experienced weakness, dizziness and painful, shock-like pains down the left side of my body. I have never been one to get headaches or migraines prior to the vaccine.
Information has been received from a RN concerning a 14 yr old male who was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequently the pt experienced a severe reaction. Unspecified medical attention was sought. The pt's outcome was unk No product quality complaint was involved. Additional information has been requested.